Telomerase treatment prevents lung profibrotic pathologies associated with physiological aging.

Short/dysfunctional telomeres are at the origin of idiopathic pulmonary fibrosis (IPF) in patients mutant for telomere maintenance genes. However, it remains unknown whether physiological aging leads to short telomeres in the lung, thus leading to IPF with aging. Here, we find that physiological agi...

Descripción completa

Detalles Bibliográficos
Autores: Piñeiro-Hermida, Sergio, Autilio, Chiara, Martínez, Paula, Bosch, Fátima, Pérez-Gil, Jesús, Blasco, MA, MARTINEZ
Tipo de recurso: artículo
Fecha de publicación:2020
País:España
Institución:Instituto de Salud Carlos III (ISCIII)
Repositorio:Repisalud
Idioma:inglés
OAI Identifier:oai:repisalud.isciii.es:20.500.12105/18181
Acceso en línea:http://hdl.handle.net/20.500.12105/18181
Access Level:acceso abierto
Palabra clave:Aging
Animals
Bleomycin
Cellular Senescence
DNA Damage
Disease Models, Animal
Humans
Idiopathic Pulmonary Fibrosis
Lung
Mice
Mice, Knockout
Telomerase
Telomere
Telomere Shortening
Descripción
Sumario:Short/dysfunctional telomeres are at the origin of idiopathic pulmonary fibrosis (IPF) in patients mutant for telomere maintenance genes. However, it remains unknown whether physiological aging leads to short telomeres in the lung, thus leading to IPF with aging. Here, we find that physiological aging in wild-type mice leads to telomere shortening and a reduced proliferative potential of alveolar type II cells and club cells, increased cellular senescence and DNA damage, increased fibroblast activation and collagen deposits, and impaired lung biophysics, suggestive of a fibrosis-like pathology. Treatment of both wild-type and telomerase-deficient mice with telomerase gene therapy prevented the onset of lung profibrotic pathologies. These findings suggest that short telomeres associated with physiological aging are at the origin of IPF and that a potential treatment for IPF based on telomerase activation would be of interest not only for patients with telomerase mutations but also for sporadic cases of IPF associated with physiological aging.